The level of ASMA expression was measured by immunofluorescent staining and the percentage of inhibition of ASMA expression was reported for each shRNA tested with dermal fibroblasts from the two SSc donors (Fig. 4A). The gene discussed is ACTA1; the disease is systemic sclerosis.